Lege artis - Das Magazin zur ärztlichen Weiterbildung, Table of Contents Frauenheilkunde up2date 2013; 7(3): 223-234DOI: 10.1055/s-0032-1325059 Geburtshilfe und Perinatalmedizin Georg Thieme Verlag KG Stuttgart · New York Die Frühgeburt – Prävention, Diagnose und Interventionen H. Helmer Recommend Article Abstract Buy Article Full Text References Literatur 1 Beck S, Wojdyla D, Say L et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 2010; 88: 31-38 2 Helmer H. Leitlinien zum Management der drohenden Frühgeburt bei Einlings- und Zwillingsschwangerschaft. Consensusmeeting 8.–9. November 2002, Pöllauberg, Stmk. 1. Update Meeting 28. April 2005, Wien. Speculum – Zeitschrift für Gynäkologie und Geburtshilfe 2006; 24: 18-24 3 Keirse MJNC. Progestogen administration in pregnancy may prevent preterm delivery. Br J Obstet Gynaecol 1990; 97: 149-154 4 Meis PJ, Klebanoff M, Thom E et al. for the National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348: 2379-2385 5 Fonseca EB, Celik E, Parra M et al. Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007; 357: 462-469 6 Kiss H, Petricevic L, Husslein P. Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. Br Med J 2004; 329: 371 7 Berghella V, Baxter JK, Hendrix NW. Cervical assessment by ultrasound for preventing preterm delivery. Cochrane Database Syst Rev 2013; (1) CD007235 8 Abbott DS, Radford SK, Seed PT et al. Evaluation of a quantitative fetal fibronectin test for spontaneous preterm birth in symptomatic women. Am J Obstet Gynecol 2013; 208: 122.e1-e6 9 http://www.studies-obsgyn.nl/eufis/index.asp 10 DeFranco EA, Lewis DF, Odibo AO. Improving the screening accuracy for preterm labor: is the combination of fetal fibronectin and cervical length in symptomatic patients a useful predictor of preterm birth? A systematic review. Am J Obstet Gynecol 2013; 208: 233.e1-6 11 Owen J, Hankins G, Iams JD et al. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynecol 2009; 201: 375.e1 12 Berghella V, Rafael TJ, Szychowski JM et al. Cerclage for short cervix on ultrasonography in women with singleton gestations and previous preterm birth: a meta-analysis. Obstet Gynecol 2011; 117: 663-671 13 Alfirevic Z, Stampalija T, Roberts D, Jorgensen AL. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. Cochrane Database Syst Rev 2012; (4) CD008991 14 MRC/RCOG Working Party on Cervical Cerclage. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomised trial of cervical cerclage. Br J Obstet Gynaecol 1993; 100: 516-523 15 de Heus R, Mol BW, Erwich JJ et al. Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study. Br Med J 2009; 338: b744 16 The Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. Br J Obstet Gynaecol 2001; 108: 133-142 17 Valenzuela GJ, Sanchez-Ramos L, Romero R et al. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group. Am J Obstet Gynecol 2000; 182: 1184-1190 18 Mercer BM, Merlino AA. Society for Maternal-Fetal Medicine. Magnesium sulfate for preterm labor and preterm birth. Obstet Gynecol 2009; 114: 650-668 19 Conde-Agudelo A, Romero R, Kusanovic JP. Nifedipine in the management of preterm labor: a systematic review and metaanalysis. Am J Obstet Gynecol 2011; 204: 134.e1 20 Bracero LA, Leikin E, Kirshenbaum N, Tejani N. Comparison of nifedipine and ritodrine for the treatment of preterm labor. Am J Perinatol 1991; 8: 365-369 21 Carlo WA, McDonald SA, Fanaroff AA et al. for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks gestation. J Am Med Assoc 2011; 306: 2348-2358 22 Stutchfield P et al. Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial. Br Med J 2005; 331: 662-664 23 Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; (3) CD004454 24 Lee BH, Stoll BJ, McDonald SA et al. National Institute of Child Health and Human Development Neonatal Research Network. Adverse neonatal outcomes associated with antenatal dexamethasone versus antenatal betamethasone. Pediatrics 2006; 117: 1503-1510 25 Lee M-J, Guinn D, Lockwood CJ. Antenatal use of corticosteroids in women at risk for preterm delivery. UpToDate 2012 26 Crowther CA, Haslam RR, Hiller JE et al. Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet 2006; 367: 1913-1919 27 Doyle LW, Crowther CA, Middleton P et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009; (1) CD004661 28 ACOG Committee Opinion No. 475: Antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol 2011; 117: 422-424 29 Crowther CA, Hiller JE, Doyle LW et al. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. J Am Med Assoc 2003; 290: 2669 30 American College of Obstetricians and Gynecologists Committee on Obstetric Practice, Society for Maternal-Fetal Medicine. Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection. Obstet Gynecol 2010; 115: 669-671 31 Centers for Disease Control and Prevention. Prevention of Perinatal Group B Streptococcal Disease. Revised Guidelines from CDC, 2010. MMWR 2010; 5 No. RR-10 32 Yancey MK, Schuchat A, Brown LK et al. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996; 88: 811-815
